95449 ⎘
Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups - , , or in which the condensed system contains three hetero rings; Ortho-condensed systems the condensed system containing two rings with oxygen as ring hetero atom and one ring with nitrogen as ring hetero atom
NOVEL ORGANIC COMPOUND, PHOTODIODE INCLUDING SAME, ELECTRONIC APPARATUS INCLUDING SAME PHOTODIODE
#2Piperidinone Derivatives as MDM2 Inhibitors for the Treatment of Cancer
#3BILOBALIDE DERIVATIVE COMPOUNDS FOR TREATING NEUROLOGICAL DISEASES AND CANCERS
#4HOST MATERIAL, COMPOSITION, AND ORGANIC ELECTROLUMINESCENT ELEMENT
#5Piperidinone Derivatives as MDM2 Inhibitors for the Treatment of Cancer
#6HETEROCYCLIC COMPOUND, ORGANIC LIGHT EMITTING DEVICE AND COMPOSITION FOR ORGANIC MATERIAL LAYER COMPRISING THE SAME
#7EIF4A-INHIBITING COMPOUNDS AND METHODS RELATED THERETO
#8FLUORESCENT COMPOUND FOR DETECTING BIOLOGICAL MATERIAL AND PREPARATION METHOD THEREOF
#9OXYNITIDINE DERIVATIVES USEFUL AS INHIBITORS OF TOPOISOMERASE IB (TOP1) AND TYROSYL-DNA PHOSPHODIESTERASE 1 (TDP1)
#10ANTI-SARS-COV-2 DRUG
#11Composition, film, organic light emitting element, method for providing light emitting composition, and program
#12Host material, composition, and organic electroluminescent element
#13SUBSTITUTED BICYCLIC AND TRICYCLIC UREAS AND AMIDES, ANALOGUES THEREOF, AND METHODS USING SAME
#14EIF4A-INHIBITING COMPOUNDS AND METHODS RELATED THERETO
#15Piperidinone Derivatives as MDM2 Inhibitors for the Treatment of Cancer
#16Organic electroluminescent material and application thereof
#17Compound and organic electronic device comprising the same
#18CYCLIC PEROXIDES AS PRODRUGS FOR SELECTIVE DELIVERY OF AGENTS
#19Analogues and derivatives of cephalotaxine and methods for making and using the compounds
#20Materials for organic electroluminescent devices
#21DRUG DELIVERY AND IMAGING CHEMICAL CONJUGATE, FORMULATIONS AND METHODS OF USE THEREOF
#22Piperidinone Derivatives as MDM2 Inhibitors for the Treatment of Cancer
#23Functionalized heterocycles as antiviral agents
#24Heteroacene and organic electroluminescence device using the same
#25BIFURAN-IMIDE-BASED MATERIALS AND USES THEREOF
#26KV1.3 INHIBITORS AND THEIR MEDICAL APPLICATION
#27N-hydroxyethyl didehydroazapodophyllotoxins as GBP1 inhibitors and methods of overcoming treatment resistance in cancer
#28ATF3 induction compounds
#29KV1.3 INHIBITORS AND THEIR MEDICAL APPLICATION
#30EIF4A-inhibiting compounds and methods related thereto
#31Cyclic peroxides as prodrugs for selective delivery of agents
#32Compositions and methods for inhibiting viral infection
#33Compounds and compositions for inhibition and elimination of Zika infection and uses for same
#34Condensed cyclic compound and organic light-emitting device including the same
#35Cyclic peroxides as prodrugs for selective delivery of agents
#36Organic compound and organic electroluminescent device comprising the same
#37Kv1.3 inhibitors and their medical application
#384-azapodophylotoxins compounds
#39Piperidinone Derivatives as MDM2 Inhibitors for the Treatment of Cancer
#40Substituted aminoquinazoline compounds as Aantagonist
#41Organic heterocyclic compound and light-emitting diode comprising same
#42EIF4A-inhibiting compounds and methods related thereto
#43Drug delivery and imaging chemical conjugate, formulations and methods of use thereof
#44POLYCYCLIC COMPOUND AND ORGANIC ELECTROLUMINESCENCE DEVICE INCLUDING THE SAME
#45KV1.3 inhibitors and their medical application
#46Compounds and methods for the treatment of drug resistance in cancer cells against paclitaxel
#47Heterocyclic compound and organic light-emitting device including the same
#48SANGUINARINE ANALOG PP2C INHIBITORS FOR CANCER TREATMENT
#49eIF4A-inhibiting compounds and methods related thereto
#50Bromodomain inhibitors
#51Cyclic peroxides as prodrugs for selective delivery of agents
#528-oxoprotoberberine derivative or pharmaceutically acceptable salt thereof, preparation method therefor and pharmaceutical composition for preventing or treating diseases associated with activity of NFAT5, containing same as active ingredient
#53Piperidinone derivatives as MDM2 inhibitors for the treatment of cancer
#54SANGUINARINE ANALOG PP2C INHIBITORS FOR CANCER TREATMENT
#55Condensed cyclic compound and organic light-emitting device including the same
#56Hexahydrodibenzo[a,g]quinolizine compound, preparation method thereof, pharmaceutical composition and use thereof
#57Piperidinone derivatives as MDM2 inhibitors for the treatment of cancer
#58PYRANOPYRIDONE INHIBITORS OF TANKYRASE
#59Heterocyclic compound and organic light-emitting device including the same
#60PIPERIDINONE DERIVATIVES AS MDM2 INHIBITORS FOR THE TREATMENT OF CANCER
#61Substituted 2,3-dihydro-1H-benzo[a]pyrano[2,3-c]phenazines as anti-angiogenic and anti-cancer agents
#62Tricyclic derivatives and their pharmaceutical use and compositions
#63Bi- and tricyclic indazole-substituted 1,4-dihydropyridine derivatives and uses thereof
#64Piperidinone derivatives as MDM2 inhibitors for the treatment of cancer
#65Synthesis of (+) cortistatin A and related compounds
#66Process for preparation of temsirolimus
#67Process for producing optically active chromene oxide compound
#68Trans-fused chromenoisoquinolines synthesis and methods for use
#69Spiroketal derivatives and use thereof as diabetic medicine
#70PYRANOINDAZOLE CYCLIC CARBONATES AND METHODS OF USE
#71Binding molecules and methods of use thereof
#72Colorant compounds, intermediates, and compositions
#73Berberine alpha-ketoglutarate salt, crystalline form, methods of preparation and applications thereof